ChemPartner's subsidiary plans to invest 58 million yuan in an industrial fund focusing on innovative drugs
I'm PortAI, I can summarize articles.
ChemPartner's wholly-owned subsidiary Beihai ChemPartner has signed an agreement with Shenzhen Investment Holdings Donghai Investment and other partners to jointly invest in the establishment of Shenzhen Luohu Donghai ChemPartner Pharmaceutical Industry Partnership, with a total subscription amount of 200 million yuan, of which Beihai ChemPartner contributes 58 million yuan, accounting for 29%. The partnership will focus on investing in innovative drugs and medical devices, aiming to enhance the company's capital operation capabilities and competitiveness
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments